Skip to main content

MARSHALL WACE, LLP

Position in KALV — KalVista Pharmaceuticals, Inc.

CIK 1318757 LONDON, X0

Position in KALV

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,279,337
-$1,236,677 QoQ
Shares Held
162,908
-56.1% QoQ
Ownership
0.306%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 182 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in KALV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. KALV ranks #130 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KALV

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,279,337 162,908
2025-09-30 $4,516,014 370,773
2025-06-30 $1,352,326 119,622
2025-03-31 $934,336 80,965
2024-12-31 $999,272 117,978
2024-09-30 $172,611 14,906
2024-06-30 $576,171 48,911
2024-03-31 $7,458,599 628,887
2023-09-30 $496,176 51,524
2022-12-31 $124,356 18,396
2022-06-30 $1,315,480 133,687
2022-03-31 $535,931 36,359
2021-03-31 $961,910 37,443
2020-03-31 $141,173 18,454